Gagan Deep Singh, MD
Emergency Medicine · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 23
- 7 carriers
- Offices
- 3
Offices
3 locations
Plans that list them
23 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Singh’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
23 of 23 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A142133 · Current
Licensed to practise in California · since 2016 · expires 2027-09-30 · Odessa State Medical University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$141,758
Medicare paid this office $141,758 for 821 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 311 | $44,156 | $97 |
| New patient visit (45+ min) | 347 | $41,408 | $119 |
| Short return visit (20+ min) | 193 | $17,371 | $69 |
| New patient visit (30+ min) | 150 | $11,439 | $76 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 154 | $6,610 | $40 |
See all 20 services
| Return visit (30+ min) | 311 | $44,156 | $97 |
| New patient visit (45+ min) | 347 | $41,408 | $119 |
| Short return visit (20+ min) | 193 | $17,371 | $69 |
| New patient visit (30+ min) | 150 | $11,439 | $76 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 154 | $6,610 | $40 |
| Detection test by immunoassay with direct visual observation for influenza virus | 94 | $3,260 | $16 |
| Long return visit (40+ min) | 13 | $1,629 | $125 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 79 | $1,345 | $16 |
| Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.5 cm or less | 16 | $1,081 | $68 |
| Injection of drug or substance under skin or into muscle | 65 | $966 | $11 |
| Urinalysis, manual test | 137 | $566 | $3 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 47 | $513 | $11 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 25 | $392 | $14 |
| Administration of vaccine | 19 | $340 | $18 |
| Diphtheria and tetanus vaccine (7 years or older) | 15 | $333 | $22 |
| Removal of sutures or staples | 16 | $154 | $9 |
| Inhalation treatment for airway obstruction or sputum production | 14 | $107 | $7 |
| Blood glucose (sugar) test performed by hand-held instrument | 20 | $64 | $3 |
| Blood count, hemoglobin | 27 | $63 | $2 |
| Injection, ketorolac tromethamine, per 15 mg | 37 | $40 | None |
Procedures Medicare counted
| Removal of nail tissue | 1-10 | None |
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
821 Original Medicare patients in 2024. Average age 71 · Under 65 17% · 85 and older 11% · Women 66% · Also on Medicaid 39% · Health risk score 1.19. At or below the middle of the specialty; the typical emergency medicine clinician is at 2.01.
Conditions among them: High blood pressure 73% · Diabetes 39% · Coronary heart disease 26% · Chronic kidney disease 23% · Heart failure 17% · COPD 17% · Atrial fibrillation 17% · Depression 17% · Cancer 11% · Stroke 10% · Dementia 7%.
The office billed $452,206, Medicare allowed $197,123 and paid $141,758; for 2,492 services of 65 kinds; $566 of it was for drugs given in the office and $141,192 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 821 | 2,492 | 71 | 1.19 | $452,206 | $141,758 |
| 2023 | 763 | 2,016 | 70 | 1.07 | $363,653 | $113,624 |
| 2022 | 700 | 1,603 | 71 | 1.10 | $238,098 | $98,956 |
| 2021 | 623 | 1,216 | 71 | 1.29 | $241,380 | $98,020 |
| 2020 | 420 | 794 | 70 | 2.01 | $329,899 | $69,851 |
| 2019 | 669 | 1,281 | 71 | 2.51 | $721,888 | $108,007 |
| 2018 | 773 | 1,329 | 73 | 2.44 | $990,072 | $119,769 |
| 2017 | 470 | 808 | 73 | 2.40 | $460,849 | $73,320 |
| 2016 | 86 | 108 | 72 | 1.99 | $72,598 | $10,953 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Return visit (30+ min) | 236 | $33,225 | $90 |
| New patient visit (45+ min) | 259 | $25,394 | $98 |
| Short return visit (20+ min) | 196 | $17,001 | $59 |
| New patient visit (30+ min) | 217 | $15,699 | $72 |
| Long return visit (40+ min) | 20 | $3,196 | $133 |
| New patient visit (60+ min) | 17 | $2,691 | $158 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 41 | $1,663 | $40 |
| Detection test by immunoassay with direct visual observation for influenza virus | 38 | $1,217 | $15 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 12 | $1,116 | $93 |
| Injection of drug or substance under skin or into muscle | 41 | $795 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 50 | $603 | $11 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 36 | $599 | $16 |
| Urinalysis, manual test | 124 | $535 | $3 |
| Application of nonmoveable forearm to hand splint | 11 | $365 | $33 |
| Diphtheria and tetanus vaccine (7 years or older) | 14 | $265 | $19 |
| Administration of vaccine | 15 | $219 | $15 |
| Removal of impacted ear wax by washing | 11 | $148 | $12 |
| Inhalation treatment for airway obstruction or sputum production | 13 | $99 | $7 |
| Blood glucose (sugar) test performed by hand-held instrument | 26 | $87 | $3 |
| Blood count, hemoglobin | 19 | $46 | $2 |
| Injection, ketorolac tromethamine, per 15 mg | 27 | $40 | None |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 12 | $1 | None |
2022: 15 services
| New patient visit (45+ min) | 223 | $24,858 | $111 |
| New patient visit (30+ min) | 277 | $20,346 | $73 |
| Return visit (30+ min) | 142 | $17,944 | $93 |
| Short return visit (20+ min) | 169 | $16,536 | $65 |
| New patient visit (60+ min) | 24 | $3,795 | $158 |
| Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.5 cm or less | 13 | $1,019 | $78 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 17 | $820 | $41 |
| Injection of drug or substance under skin or into muscle | 34 | $599 | $10 |
| Detection test by immunoassay with direct visual observation for influenza virus | 15 | $454 | $16 |
| Urinalysis, manual test | 105 | $422 | $3 |
| Diphtheria and tetanus vaccine (7 years or older) | 17 | $335 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 29 | $309 | $10 |
| Removal of impacted ear wax by washing | 20 | $293 | $12 |
| Administration of vaccine | 18 | $224 | $12 |
| Injection, ketorolac tromethamine, per 15 mg | 18 | $27 | None |
2021: 14 services
| New patient visit (45+ min) | 193 | $25,895 | $134 |
| New patient visit (30+ min) | 239 | $21,778 | $91 |
| Return visit (30+ min) | 93 | $13,681 | $109 |
| Short return visit (20+ min) | 108 | $12,253 | $77 |
| Emergency department visit with high level of medical decision making | 32 | $4,870 | $152 |
| Critical care, first 30-74 minutes | 13 | $2,794 | $215 |
| New patient visit (60+ min) | 15 | $2,730 | $182 |
| Injection of drug or substance under skin or into muscle | 18 | $435 | $12 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, dna, spike protein, adenovirus type 26 (ad26) vector, preservative free, 5x1010 viral particles/0.5ml dosage; single dose | 12 | $392 | $33 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; first dose | 12 | $362 | $30 |
| Urinalysis, manual test | 71 | $314 | $3 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | $251 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 27 | $154 | $6 |
| Injection, ketorolac tromethamine, per 15 mg | 11 | $9 | None |
2020: 12 services
| Emergency department visit with high level of medical decision making | 97 | $13,327 | $136 |
| New patient visit (45+ min) | 102 | $12,496 | $123 |
| Critical care, first 30-74 minutes | 54 | $9,756 | $174 |
| Initial hospital observation care per day, typically 70 minutes | 49 | $7,018 | $143 |
| New patient visit (60+ min) | 33 | $5,105 | $155 |
| Return visit (30+ min) | 38 | $5,058 | $87 |
| Emergency department visit with moderate level of medical decision making | 32 | $2,799 | $87 |
| Short return visit (20+ min) | 37 | $2,695 | $59 |
| New patient visit (30+ min) | 28 | $2,246 | $80 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 131 | $944 | $7 |
| Hospital observation care on day of discharge | 15 | $889 | $59 |
| Injection of drug or substance under skin or into muscle | 11 | $148 | $11 |
2019: 8 services
| Emergency department visit with high level of medical decision making | 293 | $39,986 | $133 |
| Critical care, first 30-74 minutes | 202 | $36,645 | $178 |
| Initial hospital observation care per day, typically 70 minutes | 88 | $13,170 | $150 |
| Emergency department visit with moderate level of medical decision making | 66 | $6,040 | $92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 399 | $2,945 | $7 |
| Hospital observation care on day of discharge | 32 | $1,896 | $59 |
| Emergency department visit with low level of medical decision making | 14 | $641 | $46 |
| X-ray of chest, 1 view | 27 | $202 | $7 |
2018: 6 services
| Emergency department visit with high level of medical decision making | 373 | $51,223 | $134 |
| Critical care, first 30-74 minutes | 256 | $46,886 | $177 |
| Emergency department visit with moderate level of medical decision making | 81 | $7,330 | $90 |
| Initial hospital observation care per day, typically 70 minutes | 38 | $5,668 | $149 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 441 | $3,305 | $7 |
| Emergency department visit with low level of medical decision making | 27 | $1,353 | $48 |
2017: 6 services
| Emergency department visit with high level of medical decision making | 288 | $41,037 | $138 |
| Critical care, first 30-74 minutes | 96 | $17,796 | $180 |
| Emergency department visit with moderate level of medical decision making | 57 | $5,327 | $93 |
| Initial hospital observation care per day, typically 70 minutes | 22 | $3,466 | $151 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 257 | $1,902 | $7 |
| Emergency department visit with low level of medical decision making | 12 | $545 | $45 |
2016: 3 services
| Emergency department visit with high level of medical decision making | 57 | $7,913 | $139 |
| Emergency department visit with moderate level of medical decision making | 19 | $1,859 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 16 | $111 | $7 |
Medicaid work
$1,241,291 in 2024
Medicaid paid $1,241,291 for 27,647 billed services this clinician did in 2024, up to 458 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 4,543 | $544,702 |
| New patient visit (45+ min) | 1,956 | $320,924 |
| Short return visit (20+ min) | 1,883 | $158,007 |
| New patient visit (30+ min) | 829 | $89,812 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 1,893 | $73,616 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 3,012 | $25,695 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 1,549 | $10,425 |
| Long return visit (40+ min) | 30 | $5,943 |
| New patient visit (60+ min) | 25 | $5,532 |
| URINE PREGNANCY TEST | 633 | $1,725 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 930 | $1,503 |
| Injection, ketorolac tromethamine, per 15 mg | 235 | $1,314 |
| 2024 | 27,647 | 25 | 458 | $1,241,291 |
| 2023 | 17,497 | 24 | 479 | $925,149 |
| 2022 | 10,167 | 15 | 359 | $535,777 |
| 2021 | 5,770 | 15 | 201 | $353,006 |
| 2020 | 2,338 | 17 | 104 | $175,662 |
| 2019 | 4,161 | 21 | 86 | $265,234 |
| 2018 | 4,166 | 18 | 124 | $235,164 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 3,758 | $348,616 |
| New patient visit (45+ min) | 1,820 | $234,090 |
| Short return visit (20+ min) | 2,552 | $165,878 |
| New patient visit (30+ min) | 1,362 | $129,136 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 639 | $24,747 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 1,063 | $6,925 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 841 | $6,714 |
| New patient visit (60+ min) | 14 | $2,345 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 100 | $1,863 |
| URINE PREGNANCY TEST | 662 | $1,769 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 892 | $1,372 |
| Injection, ketorolac tromethamine, per 15 mg | 210 | $929 |
2022
| New patient visit (30+ min) | 1,943 | $161,764 |
| New patient visit (45+ min) | 1,613 | $158,531 |
| Return visit (30+ min) | 2,149 | $114,067 |
| Short return visit (20+ min) | 2,690 | $91,345 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 371 | $2,504 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 206 | $1,686 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 40 | $1,410 |
| New patient visit (60+ min) | 12 | $1,308 |
| URINE PREGNANCY TEST | 433 | $1,157 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 539 | $826 |
| Strapping; ankle and/or foot | 23 | $436 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; respiratory syncytial virus | 32 | $267 |
2021
| New patient visit (45+ min) | 1,303 | $125,868 |
| New patient visit (30+ min) | 1,506 | $125,309 |
| Return visit (30+ min) | 981 | $49,397 |
| Short return visit (20+ min) | 1,149 | $36,232 |
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 49 | $6,324 |
| EMERGENCY DEPT VISIT MOD MDM | 30 | $3,224 |
| Long return visit (40+ min) | 25 | $1,985 |
| New patient visit (60+ min) | 13 | $1,635 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 133 | $899 |
| EMERGENCY DEPARTMENT VISIT MAY NOT REQ PHYS/QHP | 15 | $826 |
| URINE PREGNANCY TEST | 203 | $545 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 327 | $522 |
2020
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 320 | $44,530 |
| New patient visit (45+ min) | 413 | $41,015 |
| EMERGENCY DEPT VISIT MOD MDM | 239 | $24,720 |
| New patient visit (30+ min) | 252 | $20,889 |
| EMERGENCY DEPARTMENT VISIT MAY NOT REQ PHYS/QHP | 124 | $8,732 |
| EMERGENCY DEPT VISIT LOW MDM | 131 | $7,949 |
| Return visit (30+ min) | 135 | $6,357 |
| Short return visit (20+ min) | 150 | $4,942 |
| New patient visit (60+ min) | 39 | $4,680 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 24 | $3,393 |
| Long return visit (40+ min) | 28 | $2,122 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 16 | $1,429 |
2019
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 726 | $96,674 |
| EMERGENCY DEPT VISIT MOD MDM | 664 | $64,150 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 201 | $27,683 |
| EMERGENCY DEPT VISIT LOW MDM | 535 | $27,562 |
| EMERGENCY DEPARTMENT VISIT MAY NOT REQ PHYS/QHP | 313 | $21,760 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 66 | $5,965 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 54 | $5,342 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 527 | $3,720 |
| COMPREHENSIVE METABOLIC PANEL | 267 | $3,000 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 52 | $2,306 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 261 | $2,092 |
| Computed tomography, head or brain; without contrast material | 13 | $1,828 |
2018
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 778 | $78,404 |
| EMERGENCY DEPT VISIT MOD MDM | 744 | $52,516 |
| EMERGENCY DEPT VISIT LOW MDM | 875 | $38,731 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 260 | $28,438 |
| EMERGENCY DEPARTMENT VISIT MAY NOT REQ PHYS/QHP | 241 | $17,755 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 553 | $6,002 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 40 | $3,768 |
| Service | 65 | $2,350 |
| COMPREHENSIVE METABOLIC PANEL | 184 | $2,149 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 208 | $1,731 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 13 | $1,295 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 39 | $1,156 |
Money from drug and device companies
$63,660 in 2025
| 2025 | 1 | 21 | $56,000 | $63,660 |
| 2024 | 2 | 13 | $10,250 | $17,638 |
| 2023 | 1 | 1 | None | $750 |
| 2019 | 1 | 1 | None | $18 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Triclip | $63,660 | 21 payments
|
See all 21 published payments
| Abbott Laboratories | Consulting · 2025-12-25 | Triclip | $4,000 |
| Abbott Laboratories | Consulting · 2025-12-25 | Triclip | $2,000 |
| Abbott Laboratories | Consulting · 2025-12-25 | Triclip | $2,000 |
| Abbott Laboratories | Consulting · 2025-12-25 | Triclip | $2,000 |
| Abbott Laboratories | Travel · 2025-12-25 | Triclip | $2,000 |
| Abbott Laboratories | Travel · 2025-12-25 | Triclip | $222 |
| Abbott Laboratories | Meals · 2025-10-24 | Tendyne | $179 |
| Abbott Laboratories | Consulting · 2025-09-09 | Triclip | $5,000 |
| Abbott Laboratories | Consulting · 2025-09-09 | Triclip | $10,000 |
| Abbott Laboratories | Consulting · 2025-08-19 | Triclip | $4,000 |
| Abbott Laboratories | Travel · 2025-08-19 | Triclip | $1,750 |
| Abbott Laboratories | Consulting · 2025-06-24 | Triclip | $6,500 |
| Abbott Laboratories | Travel · 2025-06-24 | Triclip | $1,750 |
| Abbott Laboratories | Consulting · 2025-03-27 | Triclip | $4,500 |
| Abbott Laboratories | Consulting · 2025-03-27 | Triclip | $5,500 |
| Abbott Laboratories | Travel · 2025-03-27 | Triclip | $750 |
| Abbott Laboratories | Travel · 2025-03-27 | Triclip | $750 |
| Abbott Laboratories | Consulting · 2025-03-06 | Triclip | $6,500 |
| Abbott Laboratories | Consulting · 2025-03-06 | Triclip | $4,000 |
| Abbott Laboratories | Travel · 2025-03-06 | Triclip | $250 |
| Abbott Laboratories | Travel · 2025-03-06 | Triclip | $9 |
See earlier years (2024, 2023, 2019)
2024: $17,638
| Abbott Laboratories | None | $16,302 | 9 payments
|
| Biosense Webster | Carto 3 | $1,336 | 4 payments
|
2023: $750
| Abbott Laboratories | None | $750 | 1 payment
|
2019: $18
| AstraZeneca Pharmaceuticals LP | Brilinta | $18 | 1 payment
|
Checkups this office reported
21 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 72.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Appropriate Treatment for Upper Respiratory Infection (URI)As Medicare defines this measure | 88% | 880 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 2%That's few of the people this applied to. | 2,139 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 24%That's few of the people this applied to. | 58 |
| Breast cancer screeningEligible women who got a mammogram | 0%That's few of the people this applied to. | 1,087 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 0%That's few of the people this applied to. | 3,625 |
| Checked for fall riskOlder patients screened for fall risk | 0%That's few of the people this applied to. | 996 |
| Childhood Immunization StatusAs Medicare defines this measure | 0% | 283 |
| Chlamydia Screening for WomenAs Medicare defines this measure | 1% | 756 |
See the other 13 measures
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 1% | 79 |
| Colon cancer screeningEligible adults who got a colon cancer test | 0%That's few of the people this applied to. | 2,355 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 0%That's few of the people this applied to. | 8,915 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 1%That's few of the people this applied to. | 73 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 88%That's most of the people this applied to. Worse on this measure. | 73 |
| HIV screeningEligible patients who were screened for HIV | 2%That's few of the people this applied to. | 7,588 |
| Medications listed in the chartVisits where the current medication list was documented | 72%That's more than half. | 11,751 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 23%That's few of the people this applied to. | 4,072 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 99%That's most of the people this applied to. | 836 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 1,072 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 21% | 10,768 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 68%That's more than half. | 74 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 20%That's few of the people this applied to. | 7,636 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- Measurement and improvement at the practice and panel level
- ONC-ACB Surveillance Attestation
- Reports cases to public health electronically
- Reports immunizations to the state registry
- Reports to a public-health or clinical registry
- Uses standard treatment protocols
- Exempt from query of the prescription drug monitoring program (pdmp)
Professional record
- NPI
- 1093074429
- Licence
- CA A142133California A142133: Current · expires 2027-09-30
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207P00000X (207P00000X)
- Mailing address
- 2803 El Camino Real, Santa Clara, CA, 95051
- NPI first listed
- 2012-05-04
- NPI last updated
- 2026-04-17
- NPI record certified
- 2026-04-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3090 M St Ste 9, Merced, CA, 95348 · 88 Tully Rd Ste 114, San Jose, CA, 95111